福元医药
(601089)
| 流通市值：33.41亿 | | | 总市值：78.10亿 |
| 流通股本：2.05亿 | | | 总股本：4.80亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,547,022,297.14 | 1,655,495,417.22 | 802,722,388.57 | 3,339,636,352.62 |
| 营业收入 | 2,547,022,297.14 | 1,655,495,417.22 | 802,722,388.57 | 3,339,636,352.62 |
| 二、营业总成本 | 2,143,616,163.4 | 1,362,185,010.9 | 671,053,272.62 | 2,805,736,964.07 |
| 营业成本 | 838,284,084.34 | 551,392,156.59 | 272,589,947.45 | 1,114,278,297.06 |
| 税金及附加 | 25,148,852.12 | 16,300,060.01 | 7,642,262.46 | 35,518,689.32 |
| 销售费用 | 917,476,764.29 | 574,751,256.71 | 298,981,980.48 | 1,214,874,164.35 |
| 管理费用 | 94,368,474.11 | 57,383,623.03 | 29,519,293.67 | 138,448,917.6 |
| 研发费用 | 297,591,745.37 | 189,441,111.65 | 80,972,978.85 | 353,325,459.08 |
| 财务费用 | -29,253,756.83 | -27,083,197.09 | -18,653,190.29 | -50,708,563.34 |
| 其中:利息费用 | 2,800,493.52 | 2,005,160.82 | 970,813.16 | 5,344,034.98 |
| 其中:利息收入 | 32,122,065.94 | 29,041,462.87 | 19,626,687.14 | 56,198,728.33 |
| 加:投资收益 | 4,378,593.51 | -301,441.08 | -150,265.25 | 1,825,372.25 |
| 资产处置收益 | 8,538,534.22 | 8,439,699.79 | 7,503,003.59 | 225,870.16 |
| 资产减值损失(新) | -4,072,659.8 | -1,456,900.33 | 1,218,592.28 | -13,686,141.29 |
| 信用减值损失(新) | -752,226.13 | 31,233.71 | 526,619.48 | 2,870,035.31 |
| 其他收益 | 23,782,481.55 | 19,019,296.28 | 7,613,576.26 | 26,875,442.47 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 435,280,857.09 | 319,042,294.69 | 148,380,642.31 | 552,009,967.45 |
| 加:营业外收入 | 1,948,564.78 | 1,749,350.73 | 52,422.93 | 2,826,317.88 |
| 减:营业外支出 | 3,925,826 | 2,172,084 | 405,093.99 | 5,685,224.16 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 433,303,595.87 | 318,619,561.42 | 148,027,971.25 | 549,151,061.17 |
| 减:所得税费用 | 29,222,344.75 | 26,180,833.45 | 14,503,384.65 | 56,814,320.02 |
| 六、净利润 | 404,081,251.12 | 292,438,727.97 | 133,524,586.6 | 492,336,741.15 |
| 持续经营净利润 | 404,081,251.12 | 292,438,727.97 | 133,524,586.6 | 492,336,741.15 |
| 归属于母公司股东的净利润 | 400,949,905.3 | 290,621,292.44 | 132,577,291.6 | 488,766,964.98 |
| 少数股东损益 | 3,131,345.82 | 1,817,435.53 | 947,295 | 3,569,776.17 |
| (一)基本每股收益 | 0.85 | 0.61 | 0.28 | 1.02 |
| (二)稀释每股收益 | 0.85 | 0.61 | 0.28 | 1.02 |
| 九、综合收益总额 | 404,081,251.12 | 292,438,727.97 | 133,524,586.6 | 492,336,741.15 |
| 归属于母公司股东的综合收益总额 | 400,949,905.3 | 290,621,292.44 | 132,577,291.6 | 488,766,964.98 |
| 归属于少数股东的综合收益总额 | 3,131,345.82 | 1,817,435.53 | 947,295 | 3,569,776.17 |
| 公告日期 | 2024-10-25 | 2024-08-15 | 2024-04-24 | 2024-04-01 |
| 审计意见(境内) | | | | 标准无保留意见 |